[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Galera Therapeutics Inc (GRTX)

Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 7,546
  • Shares Outstanding, K 75,462
  • Annual Sales, $ 0 K
  • Annual Income, $ 149,050 K
  • EBIT $ -6 M
  • EBITDA $ -6 M
  • 60-Month Beta 1.77
  • Price/Sales N/A
  • Price/Cash Flow 0.12
  • Price/Book 1.93
  • Price/Earnings ttm 0.16
  • Earnings Per Share ttm 0.64
  • Most Recent Earnings $0.66 on 03/19/26
  • Next Earnings Date 05/21/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0410 +143.90%
on 04/13/26
0.1500 -33.33%
on 04/14/26
+0.0550 (+122.22%)
since 03/23/26
3-Month
0.0211 +373.93%
on 02/17/26
0.1500 -33.33%
on 04/14/26
+0.0763 (+321.94%)
since 01/23/26
52-Week
0.0151 +562.25%
on 10/20/25
0.1500 -33.33%
on 04/14/26
+0.0750 (+300.00%)
since 04/23/25

Most Recent Stories

More News
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--LEG, AVNS, GRTX, and GSAT

NEW YORK , April 22, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

AVNS : 24.71 (+0.24%)
GSAT : 81.29 (-0.06%)
GRTX : 0.1000 (unch)
LEG : 11.38 (-0.18%)
Are FORA, GRTX, WBS, TALK Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

FORA : 2.16 (+0.47%)
WBS : 71.73 (-0.60%)
TALK : 5.17 (-0.39%)
GRTX : 0.1000 (unch)
GRTX Stock Alert: Halper Sadeh LLC is Investigating Whether Galera Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior...

GRTX : 0.1000 (unch)
Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement

Combined company to operate as Obsidian Therapeutics, Inc. and to advance Obsidian’s pipeline of novel engineered TIL cell therapies for the treatment of patients with solid tumors. Obsidian’s lead...

GRTX : 0.1000 (unch)
Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement

Combined company to operate as Obsidian Therapeutics, Inc. and to advance Obsidian’s pipeline of novel engineered TIL cell therapies for the treatment of patients with solid tumors. ...

GRTX : 0.1000 (unch)
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million

Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The...

GRTX : 0.1000 (unch)
Galera Therapeutics completes acquisition of Nova Pharmaceuticals

GRTX : 0.1000 (unch)
Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates

Company on track to submit NDA to U.S. FDA for avasopasem by end of 2022 Phase 3 ROMAN trial data highlighted in an oral presentation at the 2022 American...

GRTX : 0.1000 (unch)
Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC

Rucosopasem was safe and well tolerated Early indications of anti-cancer activity and pulmonary function preservation Enrollment ongoing in the...

GRTX : 0.1000 (unch)
Galera to Present at Jefferies Healthcare Conference

MALVERN, Pa., June 02, 2022 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on...

GRTX : 0.1000 (unch)

Business Summary

Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel, proprietary therapeutics to transform radiotherapy in cancer. The company's product candidate is GC4419, a highly selective and potent small molecule dismutase mimetic which...

See More

Key Turning Points

3rd Resistance Point 0.1167
2nd Resistance Point 0.1133
1st Resistance Point 0.1067
Last Price 0.1000
1st Support Level 0.0967
2nd Support Level 0.0933
3rd Support Level 0.0867

See More

52-Week High 0.1500
Last Price 0.1000
Fibonacci 61.8% 0.0985
Fibonacci 50% 0.0826
Fibonacci 38.2% 0.0666
52-Week Low 0.0151

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.